Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
NCT02995395 is an observational study sponsored by Mayo Clinic. As of 21 Nov 2026, it is completed. It studies Eosinophilic Esophagitis and Healthy. The registry lists an enrollment of 28 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2017 and a primary completion date of 31 Aug 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02995395 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Mayo Clinic |
| Enrollment | 28 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Eosinophilic Esophagitis and Healthy |
| Start | 1 Oct 2017 |
| Primary completion | 31 Aug 2019 |
| Study completion | 31 Aug 2020 |
| Last update posted | 3 Feb 2021 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David A Katzka
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Rochester
Rochester
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02995395
Each answer restates registry values shown on this page.
What is NCT02995395?
NCT02995395 is an observational study sponsored by Mayo Clinic. It studies Eosinophilic Esophagitis and Healthy.
Who leads NCT02995395?
The registry names David A Katzka (principal investigator, Mayo Clinic) as the overall official.
Where does NCT02995395 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02995395 end?
The registry lists a primary completion date of 31 Aug 2019 and a study completion date of 31 Aug 2020. The sponsor last updated the record on 3 Feb 2021.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.